Trigelan® contains the three active substances levodopa, carbidopa and entacapone in one film-coated tablet.
Trigelan® is a medicine used to treat Parkinson’s disease.
Parkinson’s is caused by a deficiency of the neurotransmitter dopamine in the brain. Levodopa increases the amount of dopamine and thus reduces the symptoms of Parkinson’s disease. Carbidopa and entacapone improve the antiparkinsonian effects of levodopa.
| Strength | Pack size | Dosage form | Appearance |
| 50 mg/12,5 mg/200 mg | 30, 100 | Film-coated tablets |
|
| 100 mg/25 mg/200 mg | 30, 100 | Film-coated tablets |
|
| 150 mg/37,5 mg/200 mg | 30, 100 | Film-coated tablets |
|
| 200 mg/50 mg/200 mg | 30, 100 | Film-coated tablets |
|
